Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Инфекция мочевыводящих путей у больных с позвоночно-спинномозговой травмой: обзор литературы
Инфекция мочевыводящих путей у больных с позвоночно-спинномозговой травмой: обзор литературы
Салюков Р.В., Колмаков А.С., Мартов А.Г. Инфекция мочевыводящих путей у больных с позвоночно-спинномозговой травмой: обзор литературы. Consilium Medicum. 2016; 18 (7): 60–65. DOI: 10.26442/2075-1753_2016.7.60-65
________________________________________________
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Аннотация
Инфекция мочевыводящих путей является одним из наиболее частых осложнений позвоночно-спинномозговой травмы. Влияние ее на течение основного заболевания возможно в остром периоде спинального шока и прослеживается на протяжении всего последующего за ним восстановительного периода. В обзоре литературы дана оценка факторам, обусловливающим развитие инфекции мочевыводящих путей при позвоночно-спинномозговой травме, подчеркнуто влияние катетер-ассоциированной инфекции, рассмотрены вопросы диагностики, лечения и профилактики инфекций мочевыводящих путей.
Ключевые слова: осложненная инфекция мочевыводящих путей, нейрогенная дисфункция мочеиспускания, позвоночно-спинномозговая травма, детрузорно-сфинктерная диссинергия, периодическая катетеризация мочевого пузыря.
Ключевые слова: осложненная инфекция мочевыводящих путей, нейрогенная дисфункция мочеиспускания, позвоночно-спинномозговая травма, детрузорно-сфинктерная диссинергия, периодическая катетеризация мочевого пузыря.
________________________________________________
Urinary tract infection is one of the most common complication of spinal cord injury. Its influence on the course of the underlying disease is possible in the acute period of spinal shock, and can be traced throughout the subsequent recovery period. The literature review assesses the factors, which cause development of urinary tract infection in spinal cord injury patients, shows the impact of catheter-related infection and issues of diagnosis, treatment and prevention of urinary tract infection.
Key words: complicated urinary tract infection, neurogenic bladder dysfunction, spinal cord injury, detrusor-sphincter dyssynergia, intermittent bladder catheterization.
Key words: complicated urinary tract infection, neurogenic bladder dysfunction, spinal cord injury, detrusor-sphincter dyssynergia, intermittent bladder catheterization.
Полный текст
Список литературы
1. Manack A, Motsko SP, Haag-Molkenteller C. et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database. Neurourol Urodyn 2011; 30: 395–401.
2. DeJong G, Tian W, Hsieh CH et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil 2013; 94: 87–97.
3. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2015. / Perepanova T.S., Kozlov R.S., Rudnov V.A., Siniakova L.A. Antimikrobnaia terapiia i profilaktika infektsii pochek mochevyvodiashchikh putei i muzhskikh polovykh organov. Federal'nye klinicheskie rekomendatsii. M., 2015. [in Russian]
4. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 (Suppl.): 67S–79S.
5. Guilcher SJ, Craven BC, Calzavara A et al. Is the emergency department an appropriate substitute for primary care for persons with traumatic spinal cord injury. Spinal Cord 2013; 51: 202–8.
6. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014; 7 (1): e8905.
7. Yoon SB, Lee BS, Lee KD et al. Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord 2014; 52: 298–301.
8. Goetz LL, Howard M, Cipher D et al. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord 2010; 48: 51–4.
9. Merritt JL. Residual urine volume: correlate of urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil 1981; 62: 558–61.
10. De Ruz AE, García LE, Herruzo CR. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000; 164: 1285–9.
11. Jia C, Liao LM, Chen G et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 2013; 51: 487–90.
12. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
13. Vaidyanathan S., McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesical urothelium of patients with neuropathic bladder an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
14. Chaudhry R, Madden-Fuentes RJ, Ortiz TK et al. Inflammatory response to scherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J Urol 2014; 191: 1454–61.
15. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
16. Balsara ZR, Ross SS, Dolber PC et al. Enhanced Susceptibility to Urinary Tract Infection in the Spinal Cord-Injured Host with Neurogenic Bladder. Infect Immun 2013; 81: 3018–26.
17. Reid G, Nicolle LE. Asymptomatic bacteriuria in spinal cord patients and the elderly. Urol Clin North Am 1999; 26: 789–95.
18. Dahlberg A, Perttilä I, Wuokko E et al. Bladder management in persons with spinal cord lesion. Spinal Cord 2004; 42: 694–8.
19. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–63.
20. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999; 74: 131–6.
21. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
22. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
23. Hannan TJ, Totsika M, Mansfield KJ et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic E. coli bladder infection. FEMS Microbiol Rev 2012; 36: 616–48.
24. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization . J Spinal Cord Med 2009; 32: 568–73.
25. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
26. Pannek J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. J Spinal Cord Med 2011; 34: 11–5.
27. Grabe M, Bartoletti R, Bjerklund TE Johansen et al. Guidelines on Urological Infections. European Association of Urology. 2015; p. 86.
28. Jannelli ML, Wu JM, Plunkett LW et al. A randomized controlled trial of clean intermittent self-catheterization versus suprapubic catheterization after urogynecologic Surgery. Am J Obstet Gynecol 2007; 197: 1–4.
29. Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol 2012; 187: 391–7.
30. Jayawardena V, Midha M. Significance of bacteriuria in neurogenic bladder. J Spinal Cord Med 2004; 27: 102–5.
31. Hill TC, Baverstock R, Carlson KV et al. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context. Can Urol Assoc J 2013; 7: 122–30.
32. Mitsui T, Minami K, Morita H et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics? A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Translational Andrology and Urology 2016; 5: 72–87.
33. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
34. Morton SC, Shekelle PG, Adams JL et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129–38.
35 Hess MJ, Hess PE, Sullivan MR et al. Evaluation of cranberry tablets for the revention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6.
36. Darouiche RO, Green BG, Donovan WH et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 2011; 78: 341–6.
37. Martens FM, den Hollander PP, Snoek GJ et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn 2011; 30: 551–5.
38. Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67: 74–84.
39. Salameh A, Mohajer AlM, Darouiche RO. Prevention of urinary tract infections in patients with spinal cord injury. CMAJ 2015; 187: 807–11.
40. Gamé X, Castel-Lacanal Y, Bentaleb E et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008; 53: 613–8.
2. DeJong G, Tian W, Hsieh CH et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil 2013; 94: 87–97.
3. Perepanova T.S., Kozlov R.S., Rudnov V.A., Siniakova L.A. Antimikrobnaia terapiia i profilaktika infektsii pochek mochevyvodiashchikh putei i muzhskikh polovykh organov. Federal'nye klinicheskie rekomendatsii. M., 2015. [in Russian]
4. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 (Suppl.): 67S–79S.
5. Guilcher SJ, Craven BC, Calzavara A et al. Is the emergency department an appropriate substitute for primary care for persons with traumatic spinal cord injury. Spinal Cord 2013; 51: 202–8.
6. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014; 7 (1): e8905.
7. Yoon SB, Lee BS, Lee KD et al. Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord 2014; 52: 298–301.
8. Goetz LL, Howard M, Cipher D et al. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord 2010; 48: 51–4.
9. Merritt JL. Residual urine volume: correlate of urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil 1981; 62: 558–61.
10. De Ruz AE, García LE, Herruzo CR. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000; 164: 1285–9.
11. Jia C, Liao LM, Chen G et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 2013; 51: 487–90.
12. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
13. Vaidyanathan S., McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesical urothelium of patients with neuropathic bladder an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
14. Chaudhry R, Madden-Fuentes RJ, Ortiz TK et al. Inflammatory response to scherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J Urol 2014; 191: 1454–61.
15. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
16. Balsara ZR, Ross SS, Dolber PC et al. Enhanced Susceptibility to Urinary Tract Infection in the Spinal Cord-Injured Host with Neurogenic Bladder. Infect Immun 2013; 81: 3018–26.
17. Reid G, Nicolle LE. Asymptomatic bacteriuria in spinal cord patients and the elderly. Urol Clin North Am 1999; 26: 789–95.
18. Dahlberg A, Perttilä I, Wuokko E et al. Bladder management in persons with spinal cord lesion. Spinal Cord 2004; 42: 694–8.
19. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–63.
20. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999; 74: 131–6.
21. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
22. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
23. Hannan TJ, Totsika M, Mansfield KJ et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic E. coli bladder infection. FEMS Microbiol Rev 2012; 36: 616–48.
24. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization . J Spinal Cord Med 2009; 32: 568–73.
25. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
26. Pannek J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. J Spinal Cord Med 2011; 34: 11–5.
27. Grabe M, Bartoletti R, Bjerklund TE Johansen et al. Guidelines on Urological Infections. European Association of Urology. 2015; p. 86.
28. Jannelli ML, Wu JM, Plunkett LW et al. A randomized controlled trial of clean intermittent self-catheterization versus suprapubic catheterization after urogynecologic Surgery. Am J Obstet Gynecol 2007; 197: 1–4.
29. Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol 2012; 187: 391–7.
30. Jayawardena V, Midha M. Significance of bacteriuria in neurogenic bladder. J Spinal Cord Med 2004; 27: 102–5.
31. Hill TC, Baverstock R, Carlson KV et al. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context. Can Urol Assoc J 2013; 7: 122–30.
32. Mitsui T, Minami K, Morita H et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics? A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Translational Andrology and Urology 2016; 5: 72–87.
33. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
34. Morton SC, Shekelle PG, Adams JL et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129–38.
35 Hess MJ, Hess PE, Sullivan MR et al. Evaluation of cranberry tablets for the revention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6.
36. Darouiche RO, Green BG, Donovan WH et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 2011; 78: 341–6.
37. Martens FM, den Hollander PP, Snoek GJ et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn 2011; 30: 551–5.
38. Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67: 74–84.
39. Salameh A, Mohajer AlM, Darouiche RO. Prevention of urinary tract infections in patients with spinal cord injury. CMAJ 2015; 187: 807–11.
40. Gamé X, Castel-Lacanal Y, Bentaleb E et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008; 53: 613–8.
2. DeJong G, Tian W, Hsieh CH et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil 2013; 94: 87–97.
3. Перепанова Т.С., Козлов Р.С., Руднов В.А., Синякова Л.А. Антимикробная терапия и профилактика инфекций почек мочевыводящих путей и мужских половых органов. Федеральные клинические рекомендации. М., 2015. / Perepanova T.S., Kozlov R.S., Rudnov V.A., Siniakova L.A. Antimikrobnaia terapiia i profilaktika infektsii pochek mochevyvodiashchikh putei i muzhskikh polovykh organov. Federal'nye klinicheskie rekomendatsii. M., 2015. [in Russian]
4. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 (Suppl.): 67S–79S.
5. Guilcher SJ, Craven BC, Calzavara A et al. Is the emergency department an appropriate substitute for primary care for persons with traumatic spinal cord injury. Spinal Cord 2013; 51: 202–8.
6. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014; 7 (1): e8905.
7. Yoon SB, Lee BS, Lee KD et al. Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord 2014; 52: 298–301.
8. Goetz LL, Howard M, Cipher D et al. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord 2010; 48: 51–4.
9. Merritt JL. Residual urine volume: correlate of urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil 1981; 62: 558–61.
10. De Ruz AE, García LE, Herruzo CR. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000; 164: 1285–9.
11. Jia C, Liao LM, Chen G et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 2013; 51: 487–90.
12. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
13. Vaidyanathan S., McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesical urothelium of patients with neuropathic bladder an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
14. Chaudhry R, Madden-Fuentes RJ, Ortiz TK et al. Inflammatory response to scherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J Urol 2014; 191: 1454–61.
15. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
16. Balsara ZR, Ross SS, Dolber PC et al. Enhanced Susceptibility to Urinary Tract Infection in the Spinal Cord-Injured Host with Neurogenic Bladder. Infect Immun 2013; 81: 3018–26.
17. Reid G, Nicolle LE. Asymptomatic bacteriuria in spinal cord patients and the elderly. Urol Clin North Am 1999; 26: 789–95.
18. Dahlberg A, Perttilä I, Wuokko E et al. Bladder management in persons with spinal cord lesion. Spinal Cord 2004; 42: 694–8.
19. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–63.
20. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999; 74: 131–6.
21. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
22. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
23. Hannan TJ, Totsika M, Mansfield KJ et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic E. coli bladder infection. FEMS Microbiol Rev 2012; 36: 616–48.
24. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization . J Spinal Cord Med 2009; 32: 568–73.
25. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
26. Pannek J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. J Spinal Cord Med 2011; 34: 11–5.
27. Grabe M, Bartoletti R, Bjerklund TE Johansen et al. Guidelines on Urological Infections. European Association of Urology. 2015; p. 86.
28. Jannelli ML, Wu JM, Plunkett LW et al. A randomized controlled trial of clean intermittent self-catheterization versus suprapubic catheterization after urogynecologic Surgery. Am J Obstet Gynecol 2007; 197: 1–4.
29. Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol 2012; 187: 391–7.
30. Jayawardena V, Midha M. Significance of bacteriuria in neurogenic bladder. J Spinal Cord Med 2004; 27: 102–5.
31. Hill TC, Baverstock R, Carlson KV et al. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context. Can Urol Assoc J 2013; 7: 122–30.
32. Mitsui T, Minami K, Morita H et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics? A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Translational Andrology and Urology 2016; 5: 72–87.
33. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
34. Morton SC, Shekelle PG, Adams JL et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129–38.
35 Hess MJ, Hess PE, Sullivan MR et al. Evaluation of cranberry tablets for the revention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6.
36. Darouiche RO, Green BG, Donovan WH et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 2011; 78: 341–6.
37. Martens FM, den Hollander PP, Snoek GJ et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn 2011; 30: 551–5.
38. Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67: 74–84.
39. Salameh A, Mohajer AlM, Darouiche RO. Prevention of urinary tract infections in patients with spinal cord injury. CMAJ 2015; 187: 807–11.
40. Gamé X, Castel-Lacanal Y, Bentaleb E et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008; 53: 613–8.
________________________________________________
2. DeJong G, Tian W, Hsieh CH et al. Rehospitalization in the first year of traumatic spinal cord injury after discharge from medical rehabilitation. Arch Phys Med Rehabil 2013; 94: 87–97.
3. Perepanova T.S., Kozlov R.S., Rudnov V.A., Siniakova L.A. Antimikrobnaia terapiia i profilaktika infektsii pochek mochevyvodiashchikh putei i muzhskikh polovykh organov. Federal'nye klinicheskie rekomendatsii. M., 2015. [in Russian]
4. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 (Suppl.): 67S–79S.
5. Guilcher SJ, Craven BC, Calzavara A et al. Is the emergency department an appropriate substitute for primary care for persons with traumatic spinal cord injury. Spinal Cord 2013; 51: 202–8.
6. Togan T, Azap OK, Durukan E et al. The prevalence, etiologic agents and risk factors for urinary tract infection among spinal cord injury patients. Jundishapur J Microbiol 2014; 7 (1): e8905.
7. Yoon SB, Lee BS, Lee KD et al. Comparison of bacterial strains and antibiotic susceptibilities in urinary isolates of spinal cord injury patients from the community and hospital. Spinal Cord 2014; 52: 298–301.
8. Goetz LL, Howard M, Cipher D et al. Occurrence of candiduria in a population of chronically catheterized patients with spinal cord injury. Spinal Cord 2010; 48: 51–4.
9. Merritt JL. Residual urine volume: correlate of urinary tract infection in patients with spinal cord injury. Arch Phys Med Rehabil 1981; 62: 558–61.
10. De Ruz AE, García LE, Herruzo CR. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. J Urol 2000; 164: 1285–9.
11. Jia C, Liao LM, Chen G et al. Detrusor botulinum toxin A injection significantly decreased urinary tract infection in patients with traumatic spinal cord injury. Spinal Cord 2013; 51: 487–90.
12. Vasudeva P, Madersbacher H. Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored. Neurourol Urodyn 2014; 33: 95–100.
13. Vaidyanathan S., McDicken IW, Soni BM et al. Secretory immunoglobulin A in the vesical urothelium of patients with neuropathic bladder an immunohistochemical study. Spinal Cord 2000; 38: 378–81.
14. Chaudhry R, Madden-Fuentes RJ, Ortiz TK et al. Inflammatory response to scherichia coli urinary tract infection in the neurogenic bladder of the spinal cord injured host. J Urol 2014; 191: 1454–61.
15. Iversen PO, Hjeltnes N, Holm B et al. Depressed immunity and impaired proliferation of hematopoietic progenitor cells in patients with complete spinal cord injury. Blood 2000; 96: 2081–3.
16. Balsara ZR, Ross SS, Dolber PC et al. Enhanced Susceptibility to Urinary Tract Infection in the Spinal Cord-Injured Host with Neurogenic Bladder. Infect Immun 2013; 81: 3018–26.
17. Reid G, Nicolle LE. Asymptomatic bacteriuria in spinal cord patients and the elderly. Urol Clin North Am 1999; 26: 789–95.
18. Dahlberg A, Perttilä I, Wuokko E et al. Bladder management in persons with spinal cord lesion. Spinal Cord 2004; 42: 694–8.
19. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010; 50: 625–63.
20. Tambyah PA, Halvorson KT, Maki DG. A prospective study of pathogenesis of catheter-associated urinary tract infections. Mayo Clin Proc 1999; 74: 131–6.
21. Jacobsen SM, Stickler DJ, Mobley HL et al. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol Rev 2008; 21: 26–59.
22. Saint S, Chenoweth CE. Biofilms and catheter-associated urinary tract infections. Infect Dis Clin North Am 2003; 17: 411–32.
23. Hannan TJ, Totsika M, Mansfield KJ et al. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic E. coli bladder infection. FEMS Microbiol Rev 2012; 36: 616–48.
24. Massa LM, Hoffman JM, Cardenas DD. Validity, accuracy, and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization . J Spinal Cord Med 2009; 32: 568–73.
25. Ronco E, Denys P, Bernede-Bauduin C et al. Diagnostic Criteria of Urinary Tract Infection in Male Patients With Spinal Cord Injury. Neurorehabil Neural Repair 2011; 25: 351–8.
26. Pannek J. Treatment of urinary tract infection in persons with spinal cord injury: guidelines, evidence, and clinical practice. J Spinal Cord Med 2011; 34: 11–5.
27. Grabe M, Bartoletti R, Bjerklund TE Johansen et al. Guidelines on Urological Infections. European Association of Urology. 2015; p. 86.
28. Jannelli ML, Wu JM, Plunkett LW et al. A randomized controlled trial of clean intermittent self-catheterization versus suprapubic catheterization after urogynecologic Surgery. Am J Obstet Gynecol 2007; 197: 1–4.
29. Cameron AP, Rodriguez GM, Schomer KG. Systematic review of urological followup after spinal cord injury. J Urol 2012; 187: 391–7.
30. Jayawardena V, Midha M. Significance of bacteriuria in neurogenic bladder. J Spinal Cord Med 2004; 27: 102–5.
31. Hill TC, Baverstock R, Carlson KV et al. Best practices for the treatment and prevention of urinary tract infection in the spinal cord injured population: The Alberta context. Can Urol Assoc J 2013; 7: 122–30.
32. Mitsui T, Minami K, Morita H et al. Is suprapubic cystostomy an optimal urinary management in high quadriplegics? A comparative study of suprapubic cystostomy and clean intermittent catheterization. Eur Translational Andrology and Urology 2016; 5: 72–87.
33. Vigil HR, Hickling DR. Urinary tract infection in the neurogenic bladder. Transl Androl Urol 2016; 5: 72–87.
34. Morton SC, Shekelle PG, Adams JL et al. Antimicrobial prophylaxis for urinary tract infection in persons with spinal cord dysfunction. Arch Phys Med Rehabil 2002; 83: 129–38.
35 Hess MJ, Hess PE, Sullivan MR et al. Evaluation of cranberry tablets for the revention of urinary tract infections in spinal cord injured patients with neurogenic bladder. Spinal Cord 2008; 46: 622–6.
36. Darouiche RO, Green BG, Donovan WH et al. Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder. Urology 2011; 78: 341–6.
37. Martens FM, den Hollander PP, Snoek GJ et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn 2011; 30: 551–5.
38. Sievert KD, Amend B, Gakis G et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67: 74–84.
39. Salameh A, Mohajer AlM, Darouiche RO. Prevention of urinary tract infections in patients with spinal cord injury. CMAJ 2015; 187: 807–11.
40. Gamé X, Castel-Lacanal Y, Bentaleb E et al. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections. Eur Urol 2008; 53: 613–8.
Авторы
Р.В.Салюков*1, А.С.Колмаков1, А.Г.Мартов2
1 ФГАОУ ВО Российский университет дружбы народов. 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6;
2 ГБУЗ Городская клиническая больница №57 Департамента здравоохранения Москвы. 105077, Россия, Москва, ул. 11-я Парковая, д. 32
*salyukov2012@yandex.ru
1 ФГАОУ ВО Российский университет дружбы народов. 117198, Россия, Москва, ул. Миклухо-Маклая, д. 6;
2 ГБУЗ Городская клиническая больница №57 Департамента здравоохранения Москвы. 105077, Россия, Москва, ул. 11-я Парковая, д. 32
*salyukov2012@yandex.ru
________________________________________________
R.V.Salukov*1, A.S.Kolmakov1, A.G.Martov2
1 People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaia, d. 6;
2 105077, Russian Federation, Moscow, ul. 11-ia Parkovaia, d. 32
*salyukov2012@yandex.ru
1 People’s Friendship University of Russia. 117198, Russian Federation, Moscow, ul. Miklukho-Maklaia, d. 6;
2 105077, Russian Federation, Moscow, ul. 11-ia Parkovaia, d. 32
*salyukov2012@yandex.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.